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ABSTRACT FPL 64176 (FPL) is a nondihydropyridine compound that dramatically increases macroscopic inward current
through L-type calcium channels and slows activation and deactivation. To understand the mechanism by which channel
behavior is altered, we compared the effects of the drug on the kinetics and voltage dependence of ionic currents and gating
currents. Currents from a homogeneous population of channels were obtained using cloned rabbit CaV1.2 (a1C, cardiac L-type)
channels stably expressed in baby hamster kidney cells together with b1a and a2d1 subunits. We found a striking dissociation
between effects of FPL on ionic currents, which were modiﬁed strongly, and on gating currents, which were not detectably
altered. Inward ionic currents were enhanced ;5-fold for a voltage step from 90 mV to 110 mV. Kinetics of activation and
deactivation were slowed dramatically at most voltages. Curiously, however, at very hyperpolarized voltages (,250 mV),
deactivation was actually faster in FPL than in control. Gating currents were measured using a variety of inorganic ions to block
ionic current and also without blockers, by recording gating current at the reversal potential for ionic current (150 mV). Despite
the slowed kinetics of ionic currents, FPL had no discernible effect on the fundamental movements of gating charge that drive
channel gating. Instead, FPL somehow affects the coupling of charge movement to opening and closing of the pore. An
intriguing possibility is that the drug causes an inactivated state to become conducting without otherwise affecting gating
transitions.
INTRODUCTION
FPL 64176 (methyl 2,5-dimethyl-4-[2-(phenylmethyl)ben-
zoyl]-1H-pyrrole-3-carboxylate; FPL) is a calcium channel
modulator speciﬁc for the L-type (CaV1) family of voltage-
gated calcium channels (Baxter et al., 1993; Triggle, 2004).
Like the more commonly used agonist Bay K 8644, FPL
prolongs the opening of single calcium channels during
depolarization and slows channel closing upon repolariza-
tion (Rampe and Lacerda, 1991; Zheng et al., 1991; Kunze
and Rampe, 1992; Lauven et al., 1999; Fan et al., 2000). The
ability of FPL to enhance current through voltage-gated
L-type channels, while not affecting current through other
calcium channel types, has made it a useful tool for studying
physiological roles or disorders of L-type channels (Har-
dingham et al., 1997; Jinnah et al., 1999, 2000) and for
identifying L-type current within the mix of channel
subtypes that exists in most central neurons. FPL has also
been used to increase the contractility of smooth and cardiac
muscle (Zheng et al., 1991; Rampe and Dage, 1992; Rampe
et al., 1993). Swapping domains III and IV of the cloned
CaV2.3 calcium channel for CaV1.2 makes the resultant
channel insensitive to FPL (Altier et al., 2001), as does
a single point mutation in the S5–S6 pore domain of CaV1.2
domain III (Yamaguchi et al., 2000).
The strong effects of FPL binding on channel gating
kinetics suggest a major modiﬁcation of the gating mech-
anism. Understanding such modiﬁcation could shed light on
the normal mechanism of gating, especially the question of
how movement of gating charge in the S4 regions of the
channel is linked to opening and closing of the channel pore.
Gating steps affected by FPL might also be a target for mod-
ulation by physiological mechanisms that enhance L-type
calcium current. Fan and colleagues (2000) analyzed effects
of FPL on gating of native L-type calcium channels in rat
cardiac myocytes and found that despite the dramatic
enhancement and slowing of ionic currents, gating charge
movements were affected much less, with no effect of FPL
on gating current associated with activation and a modest
slowing effect on gating current associated with deactivation.
Here, we have extended these observations using heterolo-
gous expression of cloned channels to obtain L-type gating
current without interference from other voltage-dependent
channels, and with a technique to measure gating current in
the absence of inorganic calcium channel blockers, which
can modify gating. We ﬁnd no detectable effect of FPL on
kinetics or magnitude of either forward or reverse gating
current, even under the same conditions in which ionic
currents are drastically enhanced and slowed. We also ﬁnd
that the drug increases the voltage dependence of ionic
current deactivation so that at strongly hyperpolarized
voltages, tail currents actually decay faster in FPL than
in control. The results can be rationalized by a model in
which FPL has no effect on gating transitions but causes
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a previously nonconducting inactivated state to become
conducting.
METHODS
Construction of expression plasmids and a cell
line containing recombinant a1C Ca
21 channels
The pK4K plasmid (Niidome et al., 1994), which was used to express the
recombinant a1C subunit, is driven by the simian virus 40 (SV40) early
promoter and contains two polyadenylation sites (derived from the plasmid
pKCR; O’Hare et al., 1981) and a second transcription unit to direct
expression of the dihydrofolate reductase marker gene (derived from the
plasmid pAdD26SV(A) (no.3); Kaufman and Sharp, 1982). To express
CaV1.2 (a1C) Ca
21 channels, baby hamster kidney (BHK) cells were
transfected with pCAA2 (Niidome et al., 1994) using the calcium phosphate
protocol (Chen and Okayama, 1987). Cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing G-418 (600 mg/mL, Gibco
BRL, Gaithersburg, MD) to ﬁrst establish a BHK line with stable expression
of the a2d1 and b1a subunits. BHK cells were subsequently transfected with
pK4KC1, which contains the entire coding region of CaV1.2 cDNA (Mikami
et al., 1989), using Tfx-50 reagents (Promega, Madison, WI). Cells were
grown in DMEM containing methotrexate (250 nM, Sigma, St. Louis, MO)
to obtain a BHK line stably expressing the CaV1.2, a2d1, and b1a subunits.
Electrophysiological measurements and northern blot analysis were
employed to identify functional channels. Culturing conditions were as
described in Niidome et al. (1994), and cell aliquots (;500 ml) were stored
in liquid nitrogen until use.
As needed, cells were thawed, pelleted by centrifugation, and
resuspended and pelleted three times in 5 mL of DMEM cell culture
medium. Cells were ﬁnally resuspended in;20 mL of medium, and 3–4 mL
were plated onto 35-mm Primaria-coated cell culture dishes (Falcon). Dishes
were incubated at 37C for up to 10 days. On the day of recording, cells were
stripped from the culture dish by a 5-min incubation in DMEM 1 0.5 mM
added Na-EDTA, followed by trituration. The resulting cell suspension was
centrifuged for 3–4 min at 2000 rpm and resuspended in a Tyrode’s solution
containing (in mM) 150 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 glucose,
10 HEPES, pH adjusted to 7.4 with NaOH. As needed, several drops of the
cell suspension in Tyrode’s were added to the recording chamber and
allowed to settle to the bottom.
Electrophysiological methods
Currents were recorded using the whole-cell conﬁguration of the patch-
clamp technique. Patch pipettes were made from borosilicate glass tubing
(Boralex; Dynalab, Rochester, NY) and coated with Sylgard (Dow Corning,
Midland, MI). Pipettes had resistances of 0.5–2.0 MV when ﬁlled with
internal solution. After establishment of the whole-cell recording conﬁgu-
ration, the cell was lifted off the bottom of the dish and positioned in front of
an array of 12 perfusion tubes made of 250-mm internal diameter quartz
tubing connected by Teﬂon tubing to glass reservoirs. Complete solution
changes were made in,1 s by moving the cell from one solution to another.
Currents were recorded with an Axopatch 200A ampliﬁer (Axon
Instruments, Foster City, CA), ﬁltered with a corner frequency of 5 kHz
(four-pole Bessel ﬁlter), digitized (10 kHz) using a Digidata 1200 (Axon
Instruments), and stored on a computer. Compensation (80–95%) for series
resistance (typically;2.5 times higher than the pipette resistance) was used.
Only data from cells with a product of uncompensated series resistance and
peak current sufﬁciently small to give a voltage error of ,5 mV were
analyzed. Calcium channel currents and gating currents were corrected for
leak and capacitative currents ofﬂine by subtracting current elicited by
a hyperpolarization of 10 or 20 mV from the holding or prepulse potential of
120 or 140 mV (generally signal-averaged over 10–20 repetitions). The
ﬁrst sample point after a voltage jump was often removed from the record.
Data were all taken at room temperature, except for the effects of FPL on
deactivation (see Fig. 3), which were studied at ;12C for better resolution
of fast ionic tail currents.
The internal (pipette) solution consisted of, in mM, 56 CsCl, 68 CsF,
2.2 MgCl2, 4.5 EGTA, 9 HEPES, 4 MgATP, and 14 creatine phosphate
(Tris salt), adjusted to pH 7.4 with CsOH. External solution was, in mM,
160 TEA-Cl, 2 BaCl2, and 10 HEPES, pH adjusted to 7.4 with TEA-OH.
External solution included 0.6 mM tetrodotoxin to block any small
endogenous sodium current. Voltages reported are uncorrected for a junction
potential of 2 mV between the external solution and the Tyrode’s solution
in which the seal was formed. FPL 64176 was stored as a 1-mM solution in
water and diluted in the recording solution to the appropriate concentration
on the day of the experiment. We conﬁned our analysis to results obtained
with 1 mM FPL. We did a few experiments comparing the effects of 1 mM
FPL with 10 mM FPL. Unlike 1 mM drug, 10 mM drug had a slight slowing
effect on OFF charge movement (though no effect on voltage dependence or
kinetics of ON charge movement). This could represent partial immobili-
zation of charge due to inactivation, since with 10 mM FPL there was
enhanced decay of ionic current during test pulses. Since this was quite
different than the slowing of inactivation seen with 1 mM drug, a
concentration sufﬁcient to produce dramatic effects on the size of ionic cur-
rents, it may represent an additional blocking effect of high concen-
trations. We therefore conﬁned our analysis to the effects of the lower
concentration.
Modeling
Modeling was implemented in Igor (Wavemetrics, Lake Oswego, OR) using
fourth-order Runge-Kutta integration with a 4-ms step size. Results were
indistinguishable if step size was changed to 1 ms. Rate constants were of the
form k1 3 exp(V/k2), where k1 and k2 are constants and were as follows,
with kXY denoting the rate constant for channel conversion for state x to state
y: kCO¼ 13 exp(V/3.2), kOC¼ 13 exp(V/500), kOI¼ 0.01, kIO¼ 0.0039
3 exp(V/110), kCI ¼ 0.333 exp(V/3.2), kIC ¼ 0.133 exp(V/90). These
forms provide a reasonable simulation of kinetics and satisfy microscopic
reversibility. To avoid the problems associated with the strongly voltage-
dependent rate constants (kCO and kCI) becoming extremely large for large
depolarizations, these were ‘‘clipped’’ at 30 ms1 and 10 ms1, respectively
(chosen to preserve the 3:1 ratio of these rate constants). To generate
simulated currents, it was assumed that there were 5,000 channels; single-
channel current was calculated from the constant-ﬁeld current equations
with permeability to Ba (2 mM external) and Cs (139 internal). The single-
channel permeability to Ba in control was 1.2 3 107 cm/s, and the
permeability to Cs was 250 times lower, 4.8 3 1010 cm/s. For FPL-
modiﬁed channels, it was assumed that the open state had the same
permeability as in control and that the FPL-bound inactivated state became
conducting, with a Ba permeability of 1.73 107 cm/s (42% higher than the
normal open state) and Cs permeability of 4.83 1010 cm/s (the same as the
normal open state). The increased single-channel permeability to Ba was
based on the increase seen with FPL in single-channel experiments using Ba
as charge carrier (Handrock et al., 1998).
RESULTS
Effects of FPL on ionic currents
Calcium channel currents were recorded with the whole-cell
patch clamp from a cell line constructed using BHK cells
stably expressing the CaV1.2, b1a, and a2d1 calcium channel
subunits. Current was carried by 2 mM Ba21. Fig. 1 shows
calcium channel currents before and after addition of 1 mM
FPL. In the presence of FPL, peak inward currents were
much larger, and both activation and deactivation were
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dramatically slower, just as originally seen with native
calcium channels in cardiac myocytes (Rampe and Lacerda,
1991; Zheng et al., 1991). The effects of FPL were complete
within several seconds. On removal of drug, currents re-
turned to control amplitude and kinetics more slowly, with
complete reversal in ;60–90 s. In the records shown in Fig.
1, the currents were corrected for leakage current and linear
capacitative current, and the inward ionic current elicited by
depolarization was preceded by a brief outward current with
characteristics typical of gating current. It was notable that
this component of current was unaffected by FPL.
In addition to both activation and deactivation being
slower in FPL, the drug apparently slowed inactivation. In
control records, there was some decay of current evident
even during short (15-ms) depolarizations (Fig. 1 A, right),
while in the presence of FPL, current continued to rise
throughout this period. With a 100-ms depolarizing step to
110 mV, barium current decayed by ;65% in control and
much less (;25%) in the presence of FPL (Fig. 1 B).
Slowing of inactivation by FPL agrees with previous reports
with native channels in cardiac myocytes (Fan et al., 2000).
With the permeant ions used (2 mM Ba21 external and
139 mMCs1 internal), the reversal potential for ionic current
was close to150 mV, and substantial outward ionic currents
were evident for depolarizations positive to ;180 mV.
Interestingly, these currents were affected much less
dramatically by FPL than were inward currents. Fig. 2
shows the effect of FPL on currents elicited by a step to
1180 mV; peak current was increased by only ;20%, even
though in the same application of drug, peak inward current
elicited by a step to 20 mV was increased 10-fold. The
slowing of inactivation by FPL was evident for outward
currents as well as inward currents. In some other cells, there
was no detectable effect of FPL on peak current elicited by
depolarizations to 1160–180 mV, but the slowing of inacti-
vation was always present.
Since one of the most striking effects of FPL was slowing
of tail currents, we examined this effect over a wide voltage
range. We found that although FPL slowed tail currents
dramatically at voltages depolarized to 100 mV, as previ-
ously described for native channels (Rampe and Lacerda,
1991; Lauven et al., 1999; Fan et al., 2000), the effect was less
prominent at more hyperpolarized voltages. To better resolve
the kinetics of tail currents at strongly hyperpolarized
voltages, we performed a series of experiments in which the
cells were cooled to 12C. Fig. 3 shows an example in which
the effects of FPL on kinetics of channel deactivation were
examined over a wide voltage range (50 to 260 mV) at
12C. The effect of FPL in slowing tail current decay, which
can be seen most clearly after scaling the currents to the same
peak size, was smaller at160mV than at80mV. Remark-
ably, tail currents actually decayed faster in the presence of
FPL at very strongly hyperpolarized voltages (,200 mV).
Fig. 3 D illustrates the dependence on voltage of the
FIGURE 1 Enhancement of Cav1.2 currents and slowing of deactivation
by FPL. (A) Currents evoked by a 15-ms depolarization to 0 mV before and
2 s after moving the cell to an external solution containing 1 mM FPL. Right
panel shows test pulse current at higher gain. Linear leak and capacitative
currents have been subtracted; note lack of effect of FPL on initial outward
transient due to gating current. (B) Currents from a different cell evoked
by a 100-ms depolarization to 110 mV, in control and with 1 mM FPL,
showing slowing of activation and inactivation. Traces in FPL are marked
with an asterisk.
FIGURE 2 Effects on outward currents carried by internal Cs1 and on tail
currents that follow large depolarizations. Currents evoked by a 10-ms pulse
to 1180 mV followed by repolarization to 100 mV before and after
application of 1 mM FPL. (Right) Tail currents at 100 mV on faster time
base.
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predominant tail-current time constant. Under control con-
ditions, the decay of the tail current could be described very
well by a single exponential function for voltages negative to
150; for voltages positive to 150 mV, decay required
a double exponential function for a good ﬁt, with the faster
time constant accounting for 80–95% of the total. In the
presence of FPL, ﬁts required two exponentials at all voltages,
with the faster time constant accounting for 75–90% of the
total amplitude. In control, decay kinetics were moderately
voltage-dependent between50 and100 mV, but had only
very shallow voltage dependence negative to 120 mV, the
predominant time constant changing from ;0.7 ms at 120
mV to;0.6 ms at250 mV. In contrast, decay kinetics with
FPL were much more steeply voltage-dependent over the
entire voltage range (Fig. 3, D and E) and became faster than
in control in the range of 200 mV to 260 mV.
Effects of FPL on gating currents
To test whether the slowed kinetics of activation and
deactivation seen in the physiological voltage range resulted
from slower movement of the channel voltage sensors, we
recorded gating currents from these expressed cloned chan-
nels. To determine optimal experimental conditions for
measuring gating currents, we measured nonlinear charge
movements using a number of different ionic conditions.
First, we took the approach of blocking ionic current by
substitution of 2 mM Co21 for 2 mM Ba21. The currents
shown in Fig. 4 illustrate typical nonlinear charge movement
measured under these conditions. Linear capacitative cur-
rents were corrected using scaled currents evoked by steps
from 140 mV to 160 mV. Overlaid traces in Fig. 4 A are
in response to depolarizations to 90 mV, 50 mV,
10 mV,130 mV, and190 mV, followed by repolarization
to 100 mV. Detectable charge moved during depolarizing
steps positive to;80 mV. ON charge increased with larger
depolarizations and reached a saturating value positive to
;150 mV (Fig. 4 B). OFF charge at 100 mV closely
matched the ON charge for a given voltage step.
FIGURE 3 Effects of FPL on tail current deactivation kinetics as
a function of voltage. Channels were activated by a 15 ms pulse to 1100
or150 mV, and deactivation was measured with a repolarization to voltages
from 40 mV to 260 mV. (A–C) Repolarization to 80 mV, 160 mV,
and260 mV, respectively, in the same cell. In A–C, at right, the control tail
current (shaded) is scaled to the same amplitude as the tail in FPL (black). In
C, the activating pulse was decreased to 150 mV reduce amplitude of tails.
(D) Predominant tail current time constant versus voltage. In control, decay
was well-ﬁt by a single exponential from 260 to 150 mV; positive to
150 mV, a double exponential function was required; the faster time
constant, accounting for 80–95% of the total, is plotted. In FPL, ﬁts required
two exponentials at all voltages; the faster time constant, accounting for
75–90% of the total amplitude, is plotted. (E) Expanded scale for time con-
stants at hyperpolarized voltages. All measurements made at 12C.
FIGURE 4 Voltage dependence of nonlinear charge movement using
Co21 to block ionic current. (A) Nonlinear charge movements recorded in
external solution in which 2 mM Co21 replaced Ba21. Overlaid currents are
in response to 15-ms voltage pulses to 90, 50, 10, 130, and190 mV,
followed by repolarization to 100 mV, from a steady holding voltage of
120 mV. (Inset) OFF charge movement shown at higher resolution to
illustrate slow component of charge movement that follows steps to130 mV
and 190 mV. (B) Integrated charge movement evoked by the entire family
of voltage pulses from 130 mV to 190 mV. (d) ON charge movement.
(s) OFF charge movement. Fit is a single Boltzmann function ﬁt to the ON
charge movement,Qmax/[11 exp((V Vh)/k)], whereQmax is the maximal
charge movement, V is the test potential, Vh is the midpoint, and k is the
slope factor, with the indicated values.
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Interestingly, though, the OFF charge had complex kinetics.
Although there was an initial rapid phase of charge move-
ment in the ﬁrst millisecond after repolarization (similar to
the duration of the ionic tail current), this accounted for only
a fraction of the total OFF charge movement. There was also
a prolonged component of charge movement that lasted for
at least 20 ms after repolarization. For steps positive to
120 mV, this component accounted for at least half the re-
turn charge movement. It appears to be due to slow return
movement of channel voltage sensors, since unless it was
included in the integration of total charge movement, OFF
charge movement appeared smaller than ON charge
movement. With its inclusion, there was close matching of
ON and OFF charge movement at all voltages (Fig. 4 B). ON
and OFF charge movement were both saturating functions of
voltage ﬁt well by the same single Boltzmann function. Cells
that expressed no ionic currents expressed no nonlinear
charge movements (including the slow OFF gating charge).
Substitution of Co21 for Ba21 could conceivably intro-
duce errors in comparing the voltage dependence of gating
current to that of ionic current, because of differences in
screening of surface charge or in the gating behavior of the
channel. We therefore attempted to compare the voltage
dependence of ionic and gating currents under constant ionic
conditions. With Ba21 carrying ionic current, gating currents
can still be measured at the ionic reversal potential of
150 mV, where the only net current is due to ON movement
of gating charge (Fig. 5 A). To assay movement of gating
charge at lower voltages, we measured how steps to lower
voltages reduced the charge moved at 150 mV. Test pulses
to 150 mV were preceded by a 15-ms conditioning step to
voltages ranging from 130 mV to 1160 mV. After
conditioning steps to voltages insufﬁciently strong to move
gating charge, the subsequent test step to 150 mV evoked
maximal charge movement. After conditioning voltages
strong enough to move gating charge fully, the test pulse to
150 mV evoked no current, as no further charge was
available to move. Current at150 mVwas integrated (dotted
lines show integration limits), and the charge movement
plotted as a function of the full range of conditioning
voltages (Fig. 5 B). The resulting curve gives a measure of
the voltage dependence of charge movement measured
during 15-ms steps under exactly the same ionic conditions
as ionic current and not subject to complications of different
surface charge screening or different gating of the channel
due to the substitution of impermeant ions for barium.
Charge movement began at;60 mV, saturated at voltages
.120 mV, and was ﬁt reasonably well by a single
Boltzmann function with half-maximal voltage 33 mV.
ON current at 150 mV in Ba21 activated with the same
kinetics as in Co21, and the saturating charge movement
measured with the two protocols was very close when com-
pared in the same cell.
Fig. 6 compares the voltage dependence of activation of
ionic current in Ba21 (open circles) and gating current in the
same conditions (solid line) and gating current in Co21
measured after replacing Ba21 with Co21 (dashed line), all
from the same cell and expressed as a fraction of maximal
activation. Ionic current was measured by the same protocol
as in Fig. 5 A, but with the step to150 mV replaced by a step
to 60 mV, where peak tail current was measured. Peak tail
current amplitudes were measured as a function of prepulse
voltage. Activation of ionic current with this protocol was
biphasic, as seen for native L-type cardiac calcium channels
(Bean and Rios, 1989). Gating current measured under the
same ionic conditions (solid line) activated with smaller de-
polarizations and with a shallower voltage dependence than
ionic current, consistent with a requirement for cooperative
movement of multiple voltage sensors to open the channel.
When measured in the same ionic conditions, the midpoint of
charge movement (33 mV) was considerably hyperpolar-
ized relative to the midpoint of the main component of the
activation curve for ionic current (12 mV). Charge
FIGURE 5 Measurement of charge movement in the absence of blockers
at the reversal potential for ionic current. (A) ON charge movements were
recorded in 2 mM Ba21 with steps to the reversal potential of150 mV. The
step to 150 mV was preceded by 15-ms voltage steps to voltages ranging
from 130 mV to 1160 mV (delivered from 140 mV). The top panel
shows conditioning steps to 90 mV, 30 mV, and 10 mV. As the test
voltage increases, less current is available to move during the pulse
to150 mV. ON charge movement can be seen at the beginning of the steps
to 30 mV and 10 mV. The bottom panel shows conditioning steps to
120 mV, 190 mV, and 1140 mV. Note the lack of further charge
movement at150 mV after these steps. The inset shows the magniﬁcation of
gating current elicited by the step to150 mV after the different conditioning
voltages. (B) ON charge at 150 mV versus conditioning voltage. Fitted
curve is a single Boltzmann function, Qmax/[1 1 exp((V  Vh)/k)], where
Qmax is maximal charge movement, V is the test potential, Vh is the midpoint,
and k is the slope factor, with the indicated values.
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movement measured after Co21 replacement of Ba21 was
shifted ;30 mV in the depolarizing direction but had a very
similar shape, consistent with differences in screening of
surface charge between barium and cobalt ions.
Does FPL slow movement of the voltage sensors? We
examined gating currents in control and in FPL for
differences in voltage dependence, kinetics, and total magni-
tude. Fig. 7 shows ionic (top) and gating (bottom) currents
from the same cell, in control and in FPL, in response to
a voltage step to 120 mV from a holding voltage of 120
mV, with repolarization to 120 mV. Ionic currents were
measured in 2 mM Ba21. Gating currents were measured
after switching to 2 mM Co21 with an additional 50 mM
Gd31. In initial experiments, we replaced barium ions with
cadmium ions, but found that in cells expressing large
amounts of current, cadmium supported sizable inward ionic
tail currents after large depolarizations. This was most
evident in the presence of FPL, as previously reported by Fan
and colleagues (2001), but such currents were also evident
even in the absence of FPL, showing that there is some
cadmium permeability of even unmodiﬁed channels. When
Ba21 was replaced by Co21, there were no ionic tail currents
obvious in control, but FPL induced a slow component of tail
current upon repolarization that behaved as expected for
ionic tail current (not saturating with progressively larger
hyperpolarization). This apparently reﬂects ﬂux of Co21
through FPL-modiﬁed channels and interfered with mea-
surements of OFF gating charge. We found that adding
50 mM Gd31 blocked this current and gave nonlinear ON
charge movements similar to those in Co21 alone without
additional tail currents in FPL; presumably, Gd31 blocks
Co21 permeation. This combination of ions allowed us to ex-
amine the effect of FPL on gating currents over a wide voltage
range using simple voltage protocols.
The cell whose ionic and gating currents are shown in Fig.
7 for the same voltage steps was characteristic in that FPL
slowed and greatly enhanced the ionic current carried by
Ba21 (Fig. 7 A) but had no measurable effect on either the
size or kinetics of either ON or OFF gating currents (Fig. 7
B). A trivial explanation of this result would be if the drug
simply does not interact with the channel in the presence
of Co21 and Gd31. To test this possibility, we made a fast
solution change (,1 s) from a Co21 1 Gd31 solution
containing FPL to control (FPL-free) Ba21 solution; this
resulted in the immediate appearance of inward tail currents
with the prolonged deactivation kinetics typical of FPL-
modiﬁed channels (followed by gradual speeding of kinetics
typical of the washout of FPL) (not shown). Since the
solution exchange time is fast compared to the time required
for washout of FPL, these currents were evidently carried by
Ba21 ions through channels still bound to FPL. As the cell
was only exposed to FPL in Co21 1 Gd31, this shows that
FIGURE 6 Comparison of the voltage dependence of activation of ionic
current with charge movement measured in Ba21 and charge movement
measured in Co21. Fits from Fig. 4 (dashed line) and Fig. 5 (solid line), and
the peak ionic tail current (open circles), are normalized to maximum and
plotted as a function of voltage (all measurements from the same cell). Peak
tail current in 2 mM Ba21 was measured at 60 mV after a 15-ms pulse to
the indicated test voltage (holding potential 120 mV). FIGURE 7 Effects of FPL on ionic and gating currents. All currents
shown are from the same cell. Currents were evoked by a 15-ms pulse from
120 mV to120 mV, followed by repolarization to120 mV. (A) Currents
were measured in 2 mM Ba21 (shaded) and in Ba21 1 1 mM FPL (black),
after which FPL was washed off in Ba21-based solution. (B) Gating cur-
rents in response to the same protocol were then measured in 2 mM Co21
1 50 mM Gd31 (shaded) and this solution with 1 mM FPL (black).
Upon subsequent return to FPL-free Ba21 solution, inward ionic currents
with prolonged tail currents were present (not shown). The tail cur-
rents quickened as FPL was washed out, conﬁrming that FPL did bind in
the Co21 1 Gd31 solution.
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the Co211Gd31 solution did not prevent FPL binding to the
channel, and that the lack of detectable effect of FPL on gating
currents is not simply due to a lack of FPL binding under
these ionic conditions.
Fig. 8 shows ON and OFF gating currents over a range of
voltages, measured in control and in FPL. At all voltages, the
gating currents with and without FPL superimposed. Total
ON and OFF charge movement is plotted as a function of
voltage in Fig. 8 B. FPL had no detectable effects on the
amplitude, kinetics, or voltage dependence of either ON or
OFF charge movement.
We also examined the effects of FPL on ionic and gating
currents under the same ionic conditions, using the protocol
of measuring gating current with pulses to the ionic reversal
potential (Fig. 9). This experiment was designed to explore
possible effects of FPL on the kinetics of movements of OFF
charge, which, as shown in Fig. 4, appears to have both fast
and slow phases in control. Two pulses to 150 mV were
given, with the two pulses separated by a variable time at
120 mV. The ﬁrst depolarization to150 mV fully activates
all available charge movement, as shown in Fig. 5. Charge
then moves back during the repolarization to 120 mV. The
movement of OFF charge cannot be measured directly, since
it is obscured by the much larger ionic tail current, but the
extent to which charge has returned can be assayed by
a second step to 150 mV: only charge that has moved back
can move forward again during the second step to 150 mV.
Thus, by incrementing the time at120 mV, the time course
of OFF charge movement can be followed indirectly.
Consistent with the measurements using inorganic blockers,
this protocol showed that OFF charge moves in a biphasic
manner (Fig. 9 B). About half the charge returned in 2–3 ms
(comparable to the time course of the decay ionic tail cur-
rents), but it took more than 40 ms for the rest of the charge
to completely return. The biphasic recovery of ON charge
was paralleled by changes in the ionic tail current after the
FIGURE 8 Effects of FPL on gating currents at many voltages. (A)
Currents from a single cell in response to a family of test depolarizations
from a holding voltage of100 mV. Currents shown were evoked by pulses
to 30 mV, 0 mV, 130 mV, and 180 mV, followed by repolarization to
60 mV, in 2 mM Co21 1 200 mM Gd31 without (shaded) and with
(black) 1 mM FPL. Traces shown are single sweeps, leak-subtracted with
appropriately scaled currents evoked by an average of 10 or 20 steps from
100 mV to 120 mV. (B) ON (circles) and OFF (squares) charge
movement integrated from the currents above, in control (open symbols) and
in 1 mM FPL (solid symbols).
FIGURE 9 Simultaneous measurement of the effects of FPL on ionic and
gating currents. (A) Currents elicited by a family of 10 voltage jump
protocols. Each protocol (top) consisted of two 10-ms steps to the reversal
potential of 150 mV, separated by a step to 120 mV of variable duration.
The initial step to 120 mV lasted 2 ms, and each subsequent step was
incremented by 4 ms. All measurements were taken in 2 mM Ba21 with no
ionic blockers. Control currents (top row of currents) showed progressive
growth (as the step to 120 mV was lengthened) of both gating current at
the start of the second step to 150 mV and tail current after this step. The
currents in FPL are shown at two different scales: at the same scale as control
(middle row of currents) to allow comparison of gating currents, and at
a compressed scale to show the enhancement of tail currents (bottom row).
(B) Total charge movement during the ﬁrst (circles) and second (squares)
steps to 150 mV, in control (open symbols) and in FPL (solid symbols), as
a function of the interpulse time at 120 mV. ON currents at150 mV were
integrated for 6 ms, starting 0.8 ms after the onset of the voltage step.
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steps to150 mV. After a 2-ms recovery at120 mV, the tail
current was reduced to about half, and with longer periods at
120 mV, the tail after the second step gradually increased
back toward the level of that after the ﬁrst step. An in-
terpretation of the kinetics of gating current and ionic tail
current with this protocol is that some channels (about half)
enter some sort of inactivated state during the ﬁrst 10 ms
pulse to150 mV, and that charge returns much more slowly
from this state. The growth of both the ON charge movement
and the tail current associated with the second step to
150 mV then represent the slow recovery back to rest of
these inactivated channels.
After moving the cell into a solution containing 1 mM
FPL, the ionic tail currents were dramatically increased and
slowed, but gating currents were unchanged. The traces in
FPL are shown on two scales, one the same as for control,
showing the gating current for the 150-mV pulses, and one
with reduced scale to show the greatly enhanced and slowed
tail currents (Fig. 9 A, lower row). The presence of FPL had
no effect on the gating current during the ﬁrst pulse to 150
mV, and it also had no effect on the kinetics of OFF charge
movement at 120 mV as assayed by the second pulse to
150 mV; the ON charge elicited by the second pulse
returned in a biphasic manner indistinguishable from control
(Fig. 9 B). The lack of change of charge movement at 120
mV is striking because of the large effects on ionic current.
In addition to slowing the decay of the tail currents at 120
mV, there was a change in the relation of the second tail
current to the ﬁrst. In the presence of FPL, the tail current
associated with the second step to 150 mV was larger than
for the ﬁrst pulse, with an interpulse interval of 2–4 ms, in
contrast to the substantial reduction of the second tail under
control conditions. In FPL, the second tail then declined in
amplitude as the duration of time at 120 mV increased,
rather than increasing as in control. The Discussion presents
a model that can rationalize these changes.
DISCUSSION
The most fundamental result of our experiments for under-
standing the mechanism of the modiﬁcation of calcium
channels by FPL is FPL’s complete lack of effect on gating
currents. Most strikingly, the gating current experiments
show that the speed at which the channel voltage sensors
return to rest is not detectably affected by the drug, although
the signature effect of FPL is a dramatic slowing of the ionic
tail currents. Other data show that outward current is much
less affected by FPL than inward current and that FPL does
not always slow channel deactivation, but instead alters the
voltage dependence of deactivation such that deactivation is
actually faster at extreme hyperpolarizations. The modiﬁca-
tion of kinetics of ionic current under exactly the same ionic
conditions in which there is no change in gating current
shows that FPL somehow alters the coupling of charge
movement to opening and closing of the pore.
Channel transitions affected by FPL
Fig. 10 A shows a simple kinetic model for calcium channel
gating in which there are multiple voltage dependent
transitions between closed states involving charge move-
ment followed by a ﬁnal voltage-independent opening step,
similar to the gating scheme for Shaker K1 channels de-
scribed by Zagotta and Aldrich (1990). In the context of this
gating scheme, the major effects of FPL on ionic currents can
be explained by a change in a single voltage-independent
rate constant, namely a slowing of the closing rate constant
for the ﬁnal step in channel activation. Increasing the ratio of
the forward to the reverse rate constant of the ﬁnal voltage-
independent transition would produce the steady-state
enhancement of inward currents and reduction of the closing
rate constant would produce slowing of tail currents. With
this model FPL has no effect on steps involving charge
movement. However, the model still predicts a change in
gating current; in particular, OFF charge movement cannot
occur until after channel closing, so that slowing of ionic tail
currents predicts similar slowing of OFF charge movement.
This is contrary to the experimental results.
Fig. 10 B shows a model in which there is looser coupling
of channel opening to charge movement. In this model,
introduced by Marks and Jones (1992) to account for effects
of the dihydropyridine agonist (1)202–791 on single-
channel gating kinetics, there are multiple open states in
parallel with closed states, with charge movement able to
occur among the open-open transitions as well as the closed-
closed transitions. Coupling of charge movement to channel
opening is allosteric, so that it is not strictly necessary for
charge movement to be complete for channel opening to
occur. Rather, channel opening is increasingly favored as
more charge moves from the OFF to the ON position, and
conversely, channel opening stabilizes states in which charge
has moved. This scheme can account well for the rather
complex effects of dihydropyridine agonists on single
channel gating, on the assumption that the drugs stabilize
FIGURE 10 Kinetic models for calcium channel gating in which FPL
affects only nonvoltage-dependent gating steps. (A) Model based on Zagotta
and Aldrich (1990) in which four sequential activation steps involving
charge movement are followed by a nonvoltage-dependent pore-opening
step. (B) Allosteric model based on Marks and Jones (1992) in which
movement of gating charge can occur between both closed (upper row) and
open (bottom row) states and in which pore opening does not involve charge
movement but is favored by progressive movement of charge.
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the open states of the channel (Marks and Jones, 1992). The
model is also appealing for explaining the minimal effects of
agonists on gating current, since the loose coupling of
channel opening to gating charge movement means that in
the presence of drug, OFF charge movement can move back
while channels remain open, consistent with greater slowing
of ionic tail currents than movement of OFF charge
movement. However, in simulations using this model we
found that it predicted signiﬁcant slowing of OFF charge
movement when implemented with rate constants that could
reasonably simulate slowing of ionic tail currents. This is
because the stabilization of open states by the drug stabilizes
charge in the ON position indirectly, due to the coupling of
channel opening to charge movement. We were unable to
ﬁnd rate constants that could duplicate the slowing of ionic
currents without producing slowing of gating charge
movement that would have been easily detectable experi-
mentally.
Anymodel in which FPL affects gating steps predicts some
change in charge movement, since even if the gating steps
affected by drug are not voltage-dependent, they must be
coupled to voltage-dependent steps for the voltage de-
pendence and kinetics of ionic current to be affected by the
drug. We therefore considered a very different kind of model
in which drug is hypothesized to have literally no effect on
gating steps but instead changes the permeability associated
with a particular state. This class of models was stimulated by
several observations in the literature. First, both Handrock
and colleagues (1998) and Fan and colleagues (2001) have
presented evidence from single-channel recordings in native
cardiac muscle cells that FPL-modiﬁed calcium channels
have a larger single-channel conductance than in control,
implying change in pore structure by the drug. Fan and
colleagues further showed that FPL-modiﬁed channels
become permeable to Cd21, implying that the change in
pore structure may be substantial. Studies by Leuranguer and
colleagues (2003) on Bay K 8644 modiﬁcation of cardiac
L-type channels have also provided evidence that permeation
properties are affected by this drug, whose actions may share
at least some similarities with FPL; they showed that Bay K
8644-modiﬁed channels have altered rectiﬁcation properties,
apparently passing inward current but little or no outward
current. These results show that both FPL and Bay K 8644 do
more than just affect gating steps. Given that the simplest
interpretation of the gating current measurements would be
that FPL actually has no effect on gating steps, we asked
whether it might be possible to rationalize the effects of FPL
by a model in which the drug affects only ion permeation of
the channel.
Fig. 11 shows a model of this sort that can account for
many of the effects of FPL. The hypothesis is that the drug
has no effect at all on channel gating, but modiﬁes the
permeability of a gating state that is nonconducting in control
and becomes conducting in the presence of drug. For
simplicity, we performed simulations using just three states:
a single closed resting state, an open state, and a state that is
nonconducting in control and becomes conducting in drug.
We have called this state ‘‘I’’ since in control, it behaves
more or less like an inactivated state, being maximally
populated with a delay compared to the open state. We hy-
pothesize that in the presence of drug, this state passes ionic
current. In line with the results of Handrock et al. (1998) and
Fan et al. (2001) that single-channel conductance is larger in
the presence of FPL, the conductance for passing inward
current of the FPL-modiﬁed inactivated state is assumed to
be larger than for the normal open state; a 42% increase was
assumed based on the results of Handrock et al. using Ba21
as a charge carrier. If outward currents through the FPL-
modiﬁed channels also increased by this much, the effect
of FPL on peak outward currents would be much more
than observed experimentally. Thus we assumed that the
permeability for outward movement of Cs1 ions was the
FIGURE 11 Model for action of FPL based on modiﬁcation of
permeability of a normally nonconducting (inactivated) state. (A) Gating
scheme. In the absence of drug, channels interconvert between three states,
a closed state (C), occupied at rest, and two states occupied during
depolarizations, a conducting open state (O), and a nonconducting inac-
tivated state (I). During step depolarizations, entry into the open state is
faster than into the inactivated state but at equilibrium more channels are in
the inactivated state. In the presence of drug, gating transitions are
hypothesized to be exactly the same as in the absence of drug; the only
difference is that the inactivated state is conducting. (B) Current-voltage
relationships hypothesized for the open state (thick solid line) and the
‘‘inactivated’’ state with FPL present (thin solid line) and without FPL
(nonconducting, dashed line). (C) Predicted currents for step to 0 mV
followed by repolarization to 100 mV (left) and (right) time course of
relative occupancy of open (thick lines) and inactivated states (thin lines).
(D) Predicted currents for step to 1180 mV followed by repolarization
to 100 mV (left) and time course of relative occupancy of open
and inactivated states (right). Rate constants (ms-1): kCO ¼ 13 exp(V/3.2),
kOC ¼ 1 3 exp(V/500), kOI ¼ 0.01, kIO ¼ 0.0039 3 exp(V/110), kCI ¼
0.33 3 exp(V/3.2), kIC ¼ 0.13 3 exp(V/90).
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same as for normal open channels (Fig. 11 B). This implies
that the FPL-modiﬁed channels rectify differently than
normal channels, a feature that might seem excessively ad
hoc if it weren’t for recent evidence that Bay K 8644-
modiﬁed channels do have this property (Leuranguer et al.,
2003).
The model ﬁts with our main experimental results in
predicting no change at all in gating currents, since the
movement between states is not affected by drug. The in-
crease in ionic current occurs as a consequence of the
permeability of the inactivated state, and the relatively slow
time course of occupancy of this state gives rise to the
apparent slowing of activation that is characteristic of FPL
(Figs. 1 and 11 C). The permeability of the inactivated state
means that there is no longer macroscopic inactivation of
ionic currents; this is particularly striking at large depolari-
zations, where control inactivation is quite rapid. This
matches the experimental observations (Fig. 2).
According to the model, the time course of the slow tail
currents in FPL reﬂects movement of channels from the
inactivated state back to the closed state, a transition that at
physiological voltages is much slower (5- to 10-fold) than
deactivation of open channels. About half the channels
follow the slow return path after moderate depolarizations,
which would produce a slow phase of OFF gating charge. In
control, this gating step is electrically silent (at least in terms
of ionic current), whereas with FPL, it is associated with tail
currents corresponding to ionic current ﬂowing through the
modiﬁed inactivated state. This predicts that there should be
one phase of return movement of gating charge (identical in
both control and with FPL) with a similar slow time course
as tail current in FPL. The experimental results in Fig. 9 C
are consistent with this prediction.
In the model, the voltage dependence of the rate constant
for conversion of channels from the inactivated state back to
the closed state is relatively weak (e-fold for 90 mV).
However, deactivation of open channels has even weaker
voltage dependence (e-fold for 500 mV), consistent with
very little change in the time constant for control tail currents
at voltages between100 and250 mV. This has the conse-
quence that for very strong hyperpolarizations, negative to
200 mV, the movement of channels from the inactivated
state to the closed state becomes faster than deactivation of
open channels, explaining how tail currents can be faster in
FPL than control over this voltage range (Fig. 12). Since the
forward rate constants (C to O and C to I) have the same
strong voltage dependence (e-fold for 3.2 mV), the stronger
voltage dependence of the back rate constants from the
inactivated state means that more total charge movement is
associated with the conversion of channels between the
closed and inactivated states than between the closed and
open states. For charge to be conserved, this means that there
is some charge movement between the open and inactivated
states. The model matched the voltage dependence of the
kinetics of experimental currents best when the voltage
dependence of this conversion was in the reverse direction,
with the open to inactivated rate constant being independent
of voltage. The rate constants of the model shown in Fig. 11
A satisﬁed both conservation of charge and the principle of
microscopic reversibility.
Limitations of the model
Our main goal in the experiments reported here was to
investigate how particular gating steps were affected by FPL
using gating current measurements. Being led to a model in
which effects on permeation rather than gating are central
was unexpected, and different kinds of experiments will be
required to fully test predictions of the model. For example,
the model predicts two conducting states in the presence
of drug, with different single-channel amplitudes. The pre-
diction of no effects of FPL on gating charge movement is
obviously consistent with our results, and the model can also
account, in a fairly straightforward way, for the speeding of
tail currents at strongly hyperpolarized potentials, another
experimental result that we found surprising.
One limitation of the model with respect to the experi-
mental behavior of channels concerns the rectifying behavior
of the channels. We modeled the interaction of Cs1 perme-
ability and Ba21 permeability using constant ﬁeld equations,
but the actual shape of the instantaneous current-voltage
curvesofcardiaccalciumchannelshasapronouncedﬂattening
FIGURE 12 Predicted tail currents with and without FPL. Same model
and parameters as in Fig. 11. Control currents are shaded traces and currents
in FPL are black. Channels were activated by a 15-ms step from100 mV to
150 mV, and tail currents were then elicited by repolarization to voltages of
80 mV (A), 160 mV (B), or 260 mV (C). Right panels show predicted
control and FPL-modiﬁed currents scaled to match peak tail currents, as in
Fig. 3.
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near the reversal potential followed by a strong upward
curvature for outward currents, starting at voltages ;20 mV
positive to the reversal potential (Bean et al., 1984; Hess et al.,
1986; Bean, 1993). This is not captured by the model, which
therefore predicted much smaller outward currents relative to
inward currents than are actually present. In the experimental
results of Fig. 2, it is striking that FPL enhanced theCs-carried
outward current at the end of the pulse to 1180 mV by
,2-fold but enhanced the Ba-carried inward current imme-
diately following by ;10-fold. This suggests a more pro-
found change in rectiﬁcation or ionic selectivity than is
captured by the model.
With only three gating states, the model is too simple to
exactly match the gating of real channels. In particular, the
full details of inactivation of cardiac L-type calcium channels
under control conditions are much more complex than can be
captured with a single inactivated state (cf. Mitarai, 2000;
Findlay, 2002; Josephson et al., 2002b). There are un-
doubtedly multiple inactivated states for real channels, and it
would probably be more realistic to hypothesize that only
one or some subset of these inactivated states become
permeable with FPL bound. Possibly the state that becomes
permeable with FPL present might be better regarded as
a nonconducting closed state that interconverts fairly rapidly
with the normal open state (and thus limits the maximal po in
control conditions) rather than as a classical inactivated state.
Entry into the inactivated state of the model is very rapid
relative to most previous characterizations of inactivation of
cardiac L-type calcium channels. Nevertheless, the experi-
mental data do seem supportive of a rapidly entered in-
activated state, since there is clearly a fast phase of current
decay (especially apparent for large depolarizations, e.g.,
Fig. 2), and test pulses of only 10–15 ms to voltages positive
to 120 mV (Figs. 4 and 9) were sufﬁcient to induce a slow
component of OFF gating charge movement, typical of chan-
nels that have undergone voltage-dependent inactivation
(Ferreira et al., 2003).
The model assumes that rate constants for gating to and
from the inactivated state are completely unchanged when
this state becomes conducting in the presence of FPL. This
ignores that the free energy of a state may be different simply
depending on whether it is open or closed (all else being
unchanged), since it might be stabilized or destabilized by
occupancy of permeant ions or water molecules. It seems
plausible that such effects may be negligible from the
example of the W434F mutation of the Shaker potassium
channel, which renders the normal open state nonconducting
but has no detectable effect on the voltage-dependence of
charge movement (Perozo et al., 1993).
Comparison to Bay K 8644
The effects of FPL on L-type calcium channels are broadly
similar to those of S-()-Bay K 8644, the enantiomer of Bay
K 8644 that enhances ionic current and slows tail currents
(Kass, 1987). The amino acids that bind FPL are different
from those that bind Bay K 8644 (Zheng et al., 1991; Rampe
and Lacerda, 1991; see Hockerman et al., 1997), but in the
same region, since currents through chimeric channels with
minimal L-type sequence were increased by FPL as well
as by Bay K 8644 (Grabner et al., 1996). Interestingly,
however, there are clear differences between the two drugs
on both gating current and on inactivation. In contrast to our
results with FPL, studies with Bay K 8644 have shown
a hyperpolarizing shift in the voltage dependence of ON
charge movement (Josephson and Sperelakis, 1990; Hadley
and Lederer, 1992; Artigas et al., 2003) and also a slowing of
the kinetics of OFF charge movement (Hadley and Lederer,
1992; Fan et al., 2000; Artigas et al., 2003). Also, Bay K
8644 enhances rather than slows inactivation (Kass, 1987),
and the contrasting effects of Bay K 8644 and FPL on
inactivation have been clear in studies directly comparing the
two drugs on the same preparation (Rampe et al., 1993; Fan
et al., 2000; cf. Usowicz et al., 1995). Thus our model for
FPL’s actions seems unlikely to apply to Bay K 8644. On the
other hand, Bay K 8644 has been found to produce increases
in single channel current (Caffrey et al., 1986) and to change
the rectiﬁcation of channels (Leuranguer et al., 2003). Thus it
is plausible that Bay K 8644’s actions could include inducing
new permeability of gating states that are nonconducting in
control, as we propose for FPL. If so, perhaps the states
affected by Bay K 8644 are a subset of those affected by FPL
and do not include the absorbing inactivated states re-
sponsible for macroscopic inactivation.
Possible relevance to physiological modulation
Macroscopic currents carried by cardiac L-type calcium
channels can be enhanced by physiological stimuli, notably
b-adrenergic stimulation, as well as by drugs like Bay K
8644 and FPL. At the level of single channel gating, there are
intriguing parallels between modulation of channels by FPL
or dihydropyridine agonists and modulation by physiolog-
ical pathways, in particular the potentiation of long-lasting
‘‘mode 2’’ single channel openings (Yue et al., 1990; Ono
et al., 1993). Also, b-adrenergic enhancement of calcium cur-
rent is accompanied by a dramatic slowing of inactivation for
large depolarizations (Bean et al., 1984; Bean, 1993), much
like the effect of FPL at these voltages.
Current through cardiac L-type calcium channels can also
be potentiated after large depolarizations (Pietrobon and
Hess, 1990). It is clear that the changes produced by de-
polarization-induced potentiation are not identical to those
produced by Bay K 8644 (Wilkens et al., 2001). Neverthe-
less, there are some points of similarity with the potentiation
produced by Bay K 8644 and FPL and b-adrenergic
stimulation, including induction of ‘‘mode 2’’ single-channel
gating behavior (Pietrobon and Hess, 1990; Josephson et al.,
2002b). Another similarity is that both depolarization-induced
potentiation and Bay K 8644-induced potentiation alter
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rectiﬁcation properties of the channels (Leuranguer et al.,
2003), reminiscent of the changes in ionic permeability seen
with FPL (Fan et al., 2001). Also, depolarization-induced
potentiation (Josephson et al., 2002a) and FPL modiﬁcation
(Handrock et al., 1998; Fan et al., 2001) produce similar
increases in single-channel conductance. The still-emerging
elements of similarity between the actions of FPL and those of
b-adrenergic stimulation and depolarization-induced potenti-
ation raise the intriguing possibility that the model we propose
for FPL could also have application in channel modulation by
more physiological mechanisms.
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